Mounjaro During Pregnancy: the Guidance, the Gaps, and What to Do Next

You found out you're pregnant while using Mounjaro, here's what happens now

It is a situation more women are encountering as Mounjaro becomes more widely used for weight management across the UK. You have been on treatment, perhaps for several months, and a positive test has changed everything. The first thing to understand is that stopping tirzepatide promptly is the right call, not something to negotiate around or delay. Using tirzepatide during pregnancy is not considered safe, because the trials that would establish an acceptable profile have not been done, and animal studies identified developmental concerns serious enough for regulators to say clearly: not recommended.

So stop the injections, and get in touch with your GP or midwife as soon as you can. You do not need to panic. What your clinical team will want to do is review your overall health, consider any conditions that Mounjaro was managing alongside weight (such as blood-sugar control if type 2 diabetes is relevant to you), and make sure you have appropriate support in place for pregnancy. The question of how Mounjaro affects pregnancy outcomes is one clinicians take seriously, and the honest answer right now is that certainty is limited, which is precisely why stopping is the safer path.

One thing worth setting aside: the idea that because Mounjaro suppresses appetite and you may be eating less, the effect on the baby is something you can manage yourself. Weight management during pregnancy is a specialist conversation, not a self-directed one.

Contraception and planning: the advice that applies before pregnancy happens

The guidance on contraception while taking Mounjaro is specific and worth knowing in detail. Because tirzepatide slows gastric emptying, it can reduce how much of an oral contraceptive pill your body absorbs, particularly in the early weeks of treatment and after each dose increase. The NHS advises that women taking the pill should add a non-oral contraceptive method (condoms are the practical choice) during the first four weeks of starting Mounjaro and for four weeks after every dose step up. This applies to each rung of the titration schedule, not just the very beginning. For women with PCOS who are using Mounjaro, fertility can return faster than expected as weight changes, so this point carries extra weight.

The MHRA advises that effective contraception should be used throughout treatment and for a wash-out period after stopping, before trying to conceive. That wash-out period should be discussed with a prescriber or GP rather than estimated informally, the half-life of tirzepatide and the time needed for the body to clear it are clinical questions, not rough guides. Planning around Mounjaro and pregnancy more broadly deserves a dedicated conversation with your clinical team, not a decision made on the basis of a general article. The NHS England guidance on weight-management injections sets out the contraception and HRT advice that applies to tirzepatide, it is a useful reference to bring to a GP appointment.

After pregnancy: when weight management can restart safely

Breastfeeding is another period during which Mounjaro is not recommended. It is not yet known whether tirzepatide passes into breast milk, and until that is understood, the precautionary position holds. This is not a permanent barrier to future treatment, it is a defined period where the priorities sit elsewhere.

Once you have stopped breastfeeding and your doctor agrees the timing is right, weight management treatment becomes a conversation worth having again. Pregnancy and the postnatal period can make weight goals feel more pressing, not less. Restarting Mounjaro after pregnancy and breastfeeding is possible for eligible adults, but it requires a fresh clinical assessment, your health, your BMI, any conditions that have changed, and your overall circumstances will be reviewed from the beginning. No previous course of treatment carries over automatically.

At that point, the route back is a new consultation. Every prescription through our consultation service is reviewed personally by a GPhC-registered Independent Prescriber, who will assess your current situation, not the one from before your pregnancy. The NHS guidance on tirzepatide is a clear, reliable reference for what the medicine involves and who it is suitable for. Our Mounjaro information page covers how the treatment works and what to expect when you are ready to explore it again.